Civic Intelligence

Aim at Melanoma

990 • Fiscal year 2020 • EIN 56-2427805

Jan 01, 2020 to Dec 31, 2020 • Filed on Jul 01, 2021

Organization ProfileWWW.AIMATMELANOMA.ORG

View Organization Page

3040 Cutting BlvdRichmond, CA 94804

(916) 706-0599

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

28th percentile

0.01x

Higher debt load relative to assets than 28% of similar nonprofits.

2020 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2020

Liabilities / Revenue

26th percentile

0.02x

Higher debt load relative to revenue than 26% of similar nonprofits.

2020 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2020

Net Margin

75th percentile

22%

Higher net margin than 75% of similar nonprofits.

2020 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2020

Top Officer Pay

88th percentile

$181,778

Higher top officer pay than 88% of similar nonprofits.

Top officer pay equals 7.8% of source-year revenue.

2020 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2020

Asset Growth

65th percentile

14%

Faster asset growth than 65% of similar nonprofits.

2020 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2019 to 2020

Revenue Growth

34th percentile

-9.2%

Faster revenue growth than 34% of similar nonprofits.

2020 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2019 to 2020

Balance Sheet
Liabilities / Assets28th percentile

Assets

Up

$3,672,755

Up $444,594 (+14%) from 2019

Net Assets

Up

$3,622,755

Up $516,171 (+17%) from 2019

Liabilities

Down

$50,000

Down $71,577 (-59%) from 2019

Revenue And Expenses
Liabilities / Revenue26th percentileNet Margin75th percentile

Revenue

Down

$2,335,060

Down $236,588 (-9.2%) from 2019

Expenses

Down

$1,818,889

Down $218,873 (-11%) from 2019

Net Income

Down

$516,171

Down $17,715 (-3.3%) from 2019

Historical Trend

Balance Sheet Trend

Asset Growth65th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$8.0M$6.0M$4.0M$2.0M$0Assets 2010: $461,059Liabilities 2010: $2,479Net Assets 2010: $458,5802010Assets 2011: $835,775Liabilities 2011: $2,558Net Assets 2011: $833,2172011Assets 2012: $1,120,456Liabilities 2012: $0Net Assets 2012: $1,120,4562012Assets 2013: $1,182,080Liabilities 2013: $0Net Assets 2013: $1,182,0802013Assets 2014: $1,299,576Liabilities 2014: $0Net Assets 2014: $1,299,5762014Assets 2015: $1,680,474Liabilities 2015: $0Net Assets 2015: $1,680,4742015Assets 2016: $2,054,940Liabilities 2016: $0Net Assets 2016: $2,054,9402016Assets 2017: $2,398,753Liabilities 2017: $0Net Assets 2017: $2,398,7532017Assets 2018: $2,573,532Liabilities 2018: $0Net Assets 2018: $2,573,5322018Assets 2019: $3,228,161Liabilities 2019: $121,577Net Assets 2019: $3,106,5842019Assets 2020: $3,672,755Liabilities 2020: $50,000Net Assets 2020: $3,622,7552020Assets 2021: $4,688,149Liabilities 2021: $6,335Net Assets 2021: $4,681,8142021Assets 2022: $5,081,407Liabilities 2022: $8,020Net Assets 2022: $5,073,3872022Assets 2023: $6,023,375Liabilities 2023: $17,955Net Assets 2023: $6,005,4202023Assets 2024: $6,666,866Liabilities 2024: $19,708Net Assets 2024: $6,647,1582024

Highlighted filing

2020

Assets$3,672,755
Liabilities$50,000
Net Assets$3,622,755
Open 2020 Filing

Operations Trend

Revenue Growth34th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$4.0M$3.0M$2.0M$1.0M$0Expenses 2010: $746,3772010Expenses 2011: $871,4672011Expenses 2012: $865,7082012Revenue 2013: $1,242,832Expenses 2013: $1,181,208Net Income 2013: $61,6242013Revenue 2014: $1,322,017Expenses 2014: $1,204,521Net Income 2014: $117,4962014Revenue 2015: $1,650,655Expenses 2015: $1,269,757Net Income 2015: $380,8982015Revenue 2016: $1,782,881Expenses 2016: $1,408,415Net Income 2016: $374,4662016Revenue 2017: $2,415,270Expenses 2017: $2,071,457Net Income 2017: $343,8132017Revenue 2018: $2,544,308Expenses 2018: $2,369,528Net Income 2018: $174,7802018Revenue 2019: $2,571,648Expenses 2019: $2,037,762Net Income 2019: $533,8862019Revenue 2020: $2,335,060Expenses 2020: $1,818,889Net Income 2020: $516,1712020Revenue 2021: $2,901,257Expenses 2021: $1,842,198Net Income 2021: $1,059,0592021Revenue 2022: $2,586,311Expenses 2022: $2,194,738Net Income 2022: $391,5732022Revenue 2023: $3,245,381Expenses 2023: $2,313,348Net Income 2023: $932,0332023Revenue 2024: $2,971,089Expenses 2024: $2,329,351Net Income 2024: $641,7382024

Highlighted filing

2020

Revenue$2,335,060
Expenses$1,818,889
Net Income$516,171
Open 2020 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2020 to Dec 31, 2020
Signed
Jul 1, 2021
Return Version
2020v4.1
Gross Receipts
$2,374,584
Mission and Program Overview

Mission

AIM at Melanoma is globally engaged and locally invested in advancing the battle against melanoma through innovative research, legislative reform, education, and patient and caregiver support.The AIM at Melanoma website (www.aimatmelanoma.org) is the world's largest most comprehensive melanoma website for patients/caregivers/families. This website is viewed by 40,000 unique users per month in the US, Canada, Australia, and Europe. It serves to educate people around the globe about prevention, early detection, melanoma diagnosis, available treatments, and clinical trials.

To support melanoma research; to promote prevention and education among the general public and medical professionals; and to provide comprehensive and easily accessible melanoma resources for patients, survivors, and caregivers.

Balance Sheet Detail
LineBeginningEndChange
Assets
Rtn Earn Endowment Incm Other Fnds$3,106,584$3,622,755▲ $516,171
Savings and Temporary Cash Investments$2,470,124$2,503,267▲ $33,143
Cash and Non-Interest-Bearing Accounts$710,152$1,144,568▲ $434,416
Land, Buildings, and Equipment, Net$28,625$24,682▼ $3,943
Prepaid Expenses and Deferred Charges$10,459$238▼ $10,221
Pd in Cap Srpls Land Bldg Eqp Fund$0$0→ $0
Cap Stk Tr Prin Current Funds$0$0→ $0
Total Assets$3,228,161$3,672,755▲ $444,594
Other Assets Total$8,801$0▼ $8,801
Liabilities
Grants Payable$120,000$50,000▼ $70,000
Accounts Payable and Accrued Expenses$1,577--
Total Liabilities$121,577$50,000▼ $71,577
Net Assets / Fund Balance
Total Net Assets Fund Balance$3,106,584$3,622,755▲ $516,171
Total Liabilities and Net Assets / Fund Balance$3,228,161$3,672,755▲ $444,594

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings$24,682$51,319$76,001
Compensation and Service Providers
Top Officer Pay88th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Samantha GuildPresident and DirectorFT$160,080$21,698$181,778
Alicia RowellExecutive AdministratorFT$160,508-$160,508

Board Members and Trustees

NameTitle
Howard MaibachDirector
John KirkwoodDirector
Mohammed Kashani-sabetDirector
Renu GuptaDirector
Revenue and Support

Revenue Composition

Contributions and Grants
$2,133,571
Program Service Revenue
$3,620
Investment Income
$33,124
Other Revenue
$164,745
All Other Contributions
$1,905,576
Change in Net Assets
$516,171

Audited Revenue Reconciliation

Revenue per Audited Statements
$2,133,571
Revenue Not Reported on Financial Statements
$201,489
Revenue Not Reported on Form 990
$0
Other Revenue Adjustments
$201,489
Total Revenue per Audited Statements
$2,133,571
Total Revenue per Form 990
$2,335,060
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$877,241
Salaries, Compensation, and Employee Benefits$868,348
Grants and Similar Amounts Paid$73,300
Total Fundraising Expense$67,437
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Comp Disqual Persons$333,702$19,630$39,259$392,591
Current Officers, Directors, Trustees, and Key Employees$296,533$8,004$16,051$320,588
Other Employee Benefits$87,846$5,040$7,910$100,796
Grants to Domestic Orgs$73,300--$73,300
Payroll Taxes$48,049$2,107$4,217$54,373
All Other Expenses$47,620$410-$48,030
Office Expenses-$40,179-$40,179
Other Expenses$36,188--$36,188
Occupancy-$35,083-$35,083
Fees for Services Accounting-$29,530-$29,530
Insurance-$15,351-$15,351
Travel$9,542--$9,542
Depreciation Depletion-$7,238-$7,238
Total Functional Expenses$1,588,880$162,572$67,437$1,818,889

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$1,818,889
Total Expenses per Audited Statements$1,818,889
Total Expenses per Form 990$1,818,889
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Mtbc Melanoma Tissue Bank ConsortiumSan Rafael, CA-Tissue Bank$50,000
Upmc Univ of Pittsburgh Cancer InstitutePittsburgh, PA-Cancer and Melanoma Research$15,000
Ohsu Knight Cancer InstitutePortland, OR-Cancer and Melanoma Research$8,300
Fundraising, Events, and Gaming
Fundraising activities
Yes
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Direct Expenses$37,990
Fundraising Gross Income$37,990
Professional Fundraising Fees$0

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
AIM FOR THE "CURE MELANOMA WALKS"----
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“Form 990 is submitted by the accountant to the governing body for review and discussion. The president approves the filing of form 990 based on compliance and accuracy. The accountant is then given authorization to file.”

Form 990, Part VI, Section C, Line 19

“All governing documents, conflict of interest policy and applicable financial statements are available to the public upon request”

Filing and Contact Details

Filer

Filer Name
Aim at Melanoma
EIN
56-2427805
Phone
9167060599
Address
3040 CUTTING BLVD, RICHMOND, CA 94804

Signing Officer

Name
Samantha Guild
Title
President
Phone
9167060599
Signed
2021-07-01
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Samantha Guild
Formed
2004
Legal Domicile
CA
Voting Board Members
5
Independent Board Members
4
Employees
0
Volunteers
0

Preparer

Firm
Charles M Moche CPA
Address
2050 CENTER AVENUE SUITE 435, FORT LEE, NJ 07024
Preparer
Charles M Moche
Phone
2014651800
Supplemental Narrative

Additional Explanations

Form 990 Part XII Line 2C

“A committee assumes responsibility for the oversight of the audit, review or compilation of its financial statements and selection of its independent auditors. The organization did not change its oversight or selection process during the tax year.”

Financial Statement Notes

PART XI, LINE 4B - OTHER ADJUSTMENTS:

“Investment income 33,124. Sba ppp 164,745. Misc mission related income 3,620.”

Raw XML AppendixShowing 400 of 481 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt01577
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0TO SUPPORT MELANOMA RESEARCH; TO PROMOTE PREVENTION AND EDUCATION AMONG THE GENERAL PUBLIC AND MEDICAL PROFESSIONALS; AND TO PROVIDE COMPREHENSIVE AND EASILY ACCESSIBLE MELANOMA RESOURCES FOR PATIENTS, SURVIVORS, AND CAREGIVERS.
IRS990/AllOtherContributionsAmt01905576
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt0410
IRS990/AllOtherExpensesGrp/ProgramServicesAmt047620
IRS990/AllOtherExpensesGrp/TotalAmt048030
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990/BooksInCareOfDetail/PhoneNum09167060599
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt03040 CUTTING BLVD
IRS990/BooksInCareOfDetail/USAddress/CityNm0RICHMOND
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd094804
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CapStkTrPrinCurrentFundsGrp/BOYAmt00
IRS990/CapStkTrPrinCurrentFundsGrp/EOYAmt00
IRS990/CashNonInterestBearingGrp/BOYAmt0710152
IRS990/CashNonInterestBearingGrp/EOYAmt01144568
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt016051
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt08004
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0296533
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0320588
IRS990/CompDisqualPersonsGrp/FundraisingAmt039259
IRS990/CompDisqualPersonsGrp/ManagementAndGeneralAmt019630
IRS990/CompDisqualPersonsGrp/ProgramServicesAmt0333702
IRS990/CompDisqualPersonsGrp/TotalAmt0392591
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContriRptFundraisingEventAmt0227995
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt02133571
IRS990/CYGrantsAndSimilarPaidAmt073300
IRS990/CYInvestmentIncomeAmt033124
IRS990/CYOtherExpensesAmt0877241
IRS990/CYOtherRevenueAmt0164745
IRS990/CYProgramServiceRevenueAmt03620
IRS990/CYRevenuesLessExpensesAmt0516171
IRS990/CYSalariesCompEmpBnftPaidAmt0868348
IRS990/CYTotalExpensesAmt01818889
IRS990/CYTotalFundraisingExpenseAmt067437
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt02335060
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt07238
IRS990/DepreciationDepletionGrp/TotalAmt07238
IRS990/Desc0WEBSITEAIM AT MELANOMA ("AIM") IS AN INTERNATIONAL ORGANIZATION ENGAGED IN A WIDE VARIETY OF PATIENT ADVOCACY INITIATIVES. AMONG THESE IS THE MAINTENANCE OF THE MOST COMPREHENSIVE U.S. WEBSITE ON MELANOMA (WWW.AIMATMELANOMA.ORG). IN 2020, AIM REDESIGNED ITS WEBSITE AND ADDED ADDITIONAL CONTENT SO IT WOULD BETTER BE ABLE TO MEET THE NEEDS OF THE MELANOMA COMMUNITY. THIS INCLUDED MAKING IT EASIER FOR USERS TO LOCATE PERTINENT INFORMATION TO ASSIST THEM IN BETTER UNDERSTANDING THEIR MELANOMA DIAGNOSIS, DETERMINING THEIR TREATMENT OPTIONS, MANAGE THE SIDE EFFECTS OF TREATMENT, UNDERSTANDING FOLLOW-UP CARE AND ADDRESS THE PSYCHOSOCIAL ASPECTS OF THE DISEASE. THE ORGANIZATION CONTINUES TO USE VARIOUS TOOLS SUCH AS SEARCH ENGINE OPTIMIZATION AND DISTRIBUTING BROCHURES TO HEALTHCARE PROVIDERS THROUGHOUT THE U.S. TO EDUCATE MELANOMA PATIENTS ABOUT THE WEBSITE'S RESOURCES. THE WEBSITE IS ALSO UPDATED REGULARLY FOR MEDICAL ACCURACY AND WITH CONTENT RELATED TO ISSUES FACING THE MELANOMA COMMUNITY. THE U.S. WEBSITE ALONE, HAD MORE THAN 63,000 UNIQUE VISITORS EACH MONTH.PATIENT ADVOCACYAIM PROVIDED A FREE PHYSICIAN ASSISTANT ON CALL SERVICE. THROUGHOUT THE YEAR, MELANOMA PATIENTS, CAREGIVERS, AND FAMILIES REACHED OUT TO AIM'S ONCOLOGY PHYSICIAN ASSISTANT TO ASK QUESTIONS ABOUT, AMONG OTHER THINGS, THEIR/OR THEIR LOVED ONE'S MELANOMA DIAGNOSIS, TREATMENT OPTIONS, AND FOLLOW-UP CARE AS WELL AS QUESTIONS REGARDING PREVENTION AND EARLY DETECTION OF THE DISEASE. AIM ALSO COORDINATED NUMEROUS PATIENT ADVOCACY EVENTS, WHICH INCLUDE 10 PATIENT AND CAREGIVER SYMPOSIA LED BY NATIONALLY RECOGNIZED MELANOMA ONCOLOGISTS AT MAJOR CANCERS SUCH AS UPMC, MEMORIAL SLOAN KETTERING CANCER CENTER, LURIE CANCER CENTER AND MD ANDERSON CANCER CENTER. THE EVENTS WERE REFORMATED, DUE TO COVID. AIM ALSO VIDEOTAPED AND EDITED THESE SYMPOSIUMS, WHICH WERE THEN UPLOADED ONTO YOUTUBE AND AIM'S WEBSITE SO THAT THEY COULD BE VIEWED BY INDIVIDUALS IN THE U.S. AND WORLDWIDE. THESE SYMPOSIA WERE ALSO LIVE STREAMED GLOBALLY. AIM PROVIDES SUPPORT FOR PATIENTS, FAMILIES, AND SURVIVORS FOR A PROGRAM CALLED PEER CONNECT. PEER CONNECT IS A PEER-TO-PEER SUPPORT PROGRAM, AIM AT MELANOMA'S ANSWER TO THE ONGOING NEED FOR SUPPORT IN THE MELANOMA COMMUNITY. MELANOMA PATIENTS, FAMILY MEMBERS, AND CAREGIVERS WHO JOIN THE PROGRAM ARE MATCHED WITH A PEER, AND FROM THERE THE PAIR COMMUNICATE IN A WAY THAT IS COMFORTABLE FOR BOTH. MEMBERS OF PEER CONNECT PROVIDE EACH OTHER WITH KNOWLEDGE, EXPERIENCE, EMOTIONAL SUPPORT, AND MORE.AIM MAINTAINED A FACEBOOK PAGE, WHICH NOW HAS OVER 25,500 FOLLOWERS, A TWITTER ACCOUNT OF OVER 7,400 FOLLOWERS AND AN INSTAGRAM ACCOUNT OF OVER 2,100 FOLLOWERS IN ORDER TO PROVIDE OTHER SOURCES OF INFORMATION FOR THE MELANOMA COMMUNITY.AIM CONTINUED TO REPRESENT PATIENTS ON THE TWO LARGEST U.S. COOPERATIVE ONCOLOGY GROUPS, SWOG AND ECOG, THE NCCN, THE AAD GUIDELINES COMMITTEE, THE ASCO GUIDELINES COMMITTEE AND THE MELANOMA WORLD SOCIETY. AIM ALSO PRESENTS ON THE MELANOMA PATIENT PERSPECTIVE AT NUMEROUS MEETINGS BOTH IN THE U.S. AND THROUGHOUT THE WORLD, WHICH WAS IN A VIRTUAL FORMAT IN 2020. TO HELP PATIENTS UNDERSTAND THEIR DISEASE, AIM CREATED FROM THE CLINIC TO THE LIVING ROOM, A WEBINAR SERIES THAT IS LIVE STREAMED THROUGH FACEBOOK TO PROVIDE AN IN-DEPTH DISCUSSION ON A SPECIFIC TOPIC WITH A MELANOMA SPECIALIST, SUCH AS A PHYSICIAN, RESEARCHER, OR OTHER MEDICAL EXPERT. AIM ALSO CREATED BEYOND THE CLINIC: LIVING WELL WITH MELANOMA, A WEBINAR SERIES THAT IS LIVE STREAMED THROIUGH FACEBOOK TO ADDRESS THE PSYCHOSOCIAL ASPECTS OF A MELANOMA DIAGNOSIS DURING COVID. GLOBAL ADVOCACYAIM'S PATIENT ADVOCACY IS A GLOBAL EFFORT. IN 2020, AIM CONTINUED TO SUPPORT AND MENTOR PATIENT ADVOCACY GROUPS IN THE UNITED KINGDOM, PORTUGAL, GERMANY, FRANCE, ITALY, SPAIN, ISRAEL, LATIN AMERICA, BRAZIL, CANADA, AND EASTERN EUROPE. AIM ALSO BEGAN ITS SUPPORT AND MENTORING OF AN ADDITIONAL PATIENT ADVOCACY GROUP IN AUSTRALIA. AIM MADE IT POSSIBLE FOR THE PATIENT ADVOCATES TO VIRTUALLY ATTEND IN
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt01588880
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt029530
IRS990/FeesForServicesAccountingGrp/TotalAmt029530
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt03.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt13.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt460.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt540.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt421698
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/PersonNm0JOHN KIRKWOOD
IRS990/Form990PartVIISectionAGrp/PersonNm1MOHAMMED KASHANI-SABET
IRS990/Form990PartVIISectionAGrp/PersonNm2RENU GUPTA
IRS990/Form990PartVIISectionAGrp/PersonNm3HOWARD MAIBACH
IRS990/Form990PartVIISectionAGrp/PersonNm4SAMANTHA GUILD
IRS990/Form990PartVIISectionAGrp/PersonNm5ALICIA ROWELL
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt4160080
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt5160508
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/TitleTxt0DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt1DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4PRESIDENT AND DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5EXECUTIVE ADMINISTRATOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02004
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolAndSepBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd01
IRS990/FundraisingAmt0227995
IRS990/FundraisingDirectExpensesAmt037990
IRS990/FundraisingGrossIncomeAmt037990
IRS990/GainOrLossGrp/SecuritiesAmt0-18
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt05
IRS990/GrantAmt073300
IRS990/GrantsPayableGrp/BOYAmt0120000
IRS990/GrantsPayableGrp/EOYAmt050000
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt073300
IRS990/GrantsToDomesticOrgsGrp/TotalAmt073300
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt01516
IRS990/GrossReceiptsAmt02374584
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt04
IRS990/IndivRcvdGreaterThan100KCnt02
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InsuranceGrp/ManagementAndGeneralAmt015351
IRS990/InsuranceGrp/TotalAmt015351
IRS990/InvestmentIncomeGrp/ExclusionAmt033142
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt033142
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt08
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt051319
IRS990/LandBldgEquipBasisNetGrp/BOYAmt028625
IRS990/LandBldgEquipBasisNetGrp/EOYAmt024682
IRS990/LandBldgEquipCostOrOtherBssAmt076001
IRS990/LegalDomicileStateCd0CA
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt01534
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0AIM AT MELANOMA IS GLOBALLY ENGAGED AND LOCALLY INVESTED IN ADVANCING THE BATTLE AGAINST MELANOMA THROUGH INNOVATIVE RESEARCH, LEGISLATIVE REFORM, EDUCATION, AND PATIENT AND CAREGIVER SUPPORT. FOUNDED IN 2004, AIM AT MELANOMA IS THE LARGEST INTERNATIONAL MELANOMA FOUNDATION SEEKING THE CURE FOR MELANOMA. WE BELIEVE THAT THE CURE FOR MELANOMA WILL BE FOUND MORE QUICKLY BY BRINGING TOGETHER LEADING GLOBAL RESEARCHERS AND FUNDING THEIR COLLABORATIVE RESEARCH. OUR THREE PARADIGM-SHIFTING GLOBAL RESEARCH INITIATIVES, INCLUDING THE MELANOMA TISSUE BANK CONSORTIUM, ARE POISED TO RESHAPE THE FUTURE OF MELANOMA. WE ARE THE RESPECTED VOICE OF MELANOMA ACROSS THE NATION. WHEN DRUGS ARE APPROVED, LEGISLATION IS DRAFTED, AND RESEARCH IS ASSESSED, AIM IS AT THE TABLE, SPEAKING LOUDLY AND CLEARLY ON BEHALF OF PATIENTS AND THEIR FAMILIES. WE ARE TRUSTED ADVISORS FOR PHARMACEUTICAL COMPANIES, MEDICAL BOARDS, AND GOVERNMENT AGENCIES ON CRITICAL TOPICS THAT AFFECT MELANOMA PATIENTS.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt03106584
IRS990/NetAssetsOrFundBalancesEOYAmt03622755
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0-18
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0-18
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt00
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt035083
IRS990/OccupancyGrp/TotalAmt035083
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt040179
IRS990/OfficeExpensesGrp/TotalAmt040179
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrgDoesNotFollowFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt08801
IRS990/OtherAssetsTotalGrp/EOYAmt00
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt07910
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt05040
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt087846
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0100796
IRS990/OtherExpensesGrp/Desc0PHYSICIAN /NURSE EDUCAT
IRS990/OtherExpensesGrp/Desc1PATIENT EDUCATION AND S
IRS990/OtherExpensesGrp/Desc2GLOBAL ADVOCACY
IRS990/OtherExpensesGrp/Desc3WEBSITE
IRS990/OtherExpensesGrp/ProgramServicesAmt0383862
IRS990/OtherExpensesGrp/ProgramServicesAmt1217947
IRS990/OtherExpensesGrp/ProgramServicesAmt254291
IRS990/OtherExpensesGrp/ProgramServicesAmt336188
IRS990/OtherExpensesGrp/TotalAmt0383862
IRS990/OtherExpensesGrp/TotalAmt1217947
IRS990/OtherExpensesGrp/TotalAmt254291
IRS990/OtherExpensesGrp/TotalAmt336188
IRS990/OtherRevenueMiscGrp/BusinessCd0900099
IRS990/OtherRevenueMiscGrp/Desc0SBA PPP GRANT
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt0164745
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt0164745
IRS990/OtherRevenueTotalAmt0164745
IRS990/PartialLiquidationInd00
IRS990/PayrollTaxesGrp/FundraisingAmt04217
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt02107
IRS990/PayrollTaxesGrp/ProgramServicesAmt048049
IRS990/PayrollTaxesGrp/TotalAmt054373
IRS990/PdInCapSrplsLandBldgEqpFundGrp/BOYAmt00
IRS990/PdInCapSrplsLandBldgEqpFundGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt010459
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0238
IRS990/PrincipalOfficerNm0SAMANTHA GUILD
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0541900
IRS990/ProgramServiceRevenueGrp/Desc0CONSULTING
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt03620
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt03620
IRS990/ProgSrvcAccomActy2Grp/Desc0CONTINUED FROM ACCOMPLISHMENTS ONE IN SCHEDULE ONURSE/PHYSICIAN EDUCATION INITIATIVEIN OCTOBER 2016 AIM CREATED THE MELANOMA NURSE INITIATIVE (MNI). THE RECENT EXPANSION OF MELANOMA THERAPY HAS INCREASED THE COMPLEXITY OF DISEASE MANAGEMENT. PATIENTS MAY DISCONTINUE THERAPY IF NOT ADEQUATELY ENGAGED IN THEIR OWN CARE OR SUPPORTED WHEN THEY EXPERIENCE SIDE EFFECTS. AS WELL, MORE PATIENTS ARE BEING TREATED IN THE COMMUNITY SETTING, WHERE EXPERTISE IS FREQUENTLY LACKING TO ADDRESS THESE CHALLENGES. THE MNI CONSISTS OF:1. MELANOMA NURSE RESOURCE CENTER PORTAL (SEE GRAPHIC, THEMELANOMANURSE.ORG)THIS PORTAL PROVIDES A 1-STOP SHOP FOR ALL THE EDUCATIONAL MATERIALS DEVELOPEDCONTENT INCLUDES CONSENSUS STATEMENTS, SIDE-EFFECT SEARCH FUNCTIONS, CNE ACTIVITIES, A SUPPORTIVE CARE Q/A PORTAL, AND A PATIENT RESOURCE CENTER2. MELANOMA NURSE MANAGEMENT TOOLKITHELPFUL RESOURCES SUCH AS ALGORITHMS, CHECKLISTS, PRINTABLE SHEETS, AND SEARCHABLE CONTENT ON SUPPORTIVE CARE ASPECTS OF MELANOMA THERAPY (SIDE EFFECT MANAGEMENT AS WELL AS ADHERENCE ISSUES)KEY RESOURCES ON TARGETED THERAPY, IMMUNOTHERAPY, AND INTRALESIONAL IMMUNOTHERAPYONLINE RESOURCES AS WELL AS PRINT PIECES FOR DISTRIBUTION AT REGIONAL CANCER MEETING3. CJON (ONS) SUPPLEMENT ON OPTIMIZING OUTCOMES FOR MELANOMA THERAPIES7-ARTICLE SUPPLEMENT IN CJON TO INCLUDE AN INTRODUCTION BY 2 MELANOMA PHYSICIANS, AN OVERVIEW DOCUMENT FROM OUR CHAIR, AND 5 ARTICLES ON SUPPORT STRATEGIES FOR TARGETED THERAPY, IMMUNOTHERAPY, AND INTRALESIONAL IMMUNOTHERAPYARTICLES ARE MADE AVAILABLE THROUGH OPEN ACCESS LOCATED ON OUR PORTAL4. JADPRO SUPPLEMENT ON THE MANAGEMENT OF IMMUNE RELATED ADVERSE EVENTSTHIS 4-ARTICLE SUPPLEMENT IN JADPRO COVERS IMMUNO-ONCOLOGY THERAPY ESSENTIALS: PROACTIVE MANAGEMENT OF IMMUNE-RELATED ADVERSE EVENTS. BOTH THE CJON AND JADPRO SUPPLEMENTS ARE AVAILABLE AS WELL ON THE MNI WEBSITE5. JCO ONCOLOGY PRACTICE ON INTERDISCIPLINARY CARE FOR MANAGEMENT OF COMPLEX IRAES. THE ARTICLES IN THE SUPPLEMENT COVERS IMMUNO-ONCOLOGY APPLICATIONS IN CLINICAL SCENARIOSINTRODUCTION, TOXICITY MANAGEMENT OF FRONT-LINE PEMBROLIZUMAB COMBINED WITH AXITINIB IN CLEAR CELL METASTATIC RENAL CELL CARCINOMA: A CASE STUDY APPROACH, MANAGEMENT OF PNEUMONITIS AND NEUROPATHY IN PATIENTS RECEIVING PD-1BASED THERAPY FOR NONSMALL-CELL LUNG CANCER, THE MANAGEMENT OF IMMUNE-RELATED DERMATITIS AND MUCOSITIS ASSOCIATED WITH PEMBROLIZUMAB IN METASTATIC HUMAN PAPILLOMAVIRUSASSOCIATED SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX, AND ATYPICAL PRESENTATIONS AND MANAGEMENT OF ENDOCRINE AND HEPATIC IMMUNE-RELATED ADVERSE EVENTS FROM ADJUVANT IMMUNE CHECKPOINT INHIBITOR THERAPY IN STAGE III RESECTED MELANOMA. THE JCO SUPPLEMENT ARE AVAILABLE AS WELL ON THE MNI WEBSITE.6. AIM PROVIDED AN INTERACTIVE, WEB BASED EDUCATION ON BRAF/MEK INHIBITOR THERAPY FOR MELANOMA TO IMPROVE THE OUTCOMES THROUGH INDISCIPLINARY CARE. THE EDUCATION IS AVAILABLE AS WELL ON THE MNI WEBSITE.7. DEVELOPMENT OF PATIENT RESOURCE MATERIALSCUSTOMIZED PATIENT RESOURCE/EDUCATION MATERIALS (PRINTABLE PDFS) HAVE BEEN DEVELOPED THAT CAN BE DOWNLOADABLE FROM THE WEBSITE AND DISTRIBUTED BY NURSES/PHYSICIAN ASSISTANTS AND OTHER HCPSTOPICS INCLUDE THE GOALS OF THERAPY, THE SIDE EFFECTS OF THERAPIES, IMPORTANT POINTS/STRATEGIES AROUND ADHERENCE, AS WELL AS OTHER SUPPORTIVE RESOURCES, SUCH AS CALL-IN NUMBERS FOR FINANCIAL OR OTHER ASSISTANCE, ETC. SPECIFIC CONTENT ON TARGETED THERAPIES, IMMUNOTHERAPIES, COMBINATIONS, INTRALESIONAL IMMUNOTHERAPIES, AND THE ADJUVANT SETTING ARE INCLUDED.8. DEVELOPMENT OF PATIENT AND HCP VIDEOSVIDEOS HAVE BEEN DEVELOPED TO ADDRESS THE ISSUES OF PREVENTION AND EARLY DETECTION, SURGERY, PATHOLOGY, TREATMENT, SIDE EFFECTS AND MANAGMENET FOR BOTH TARGETED AND IMMUNOTHERAPIES, CLINICAL TRIALS, AND LIVING WITH MELANOMA. THE HCP VIDEOS WERE DEVELOPED TO ASSIST HCPS TO CARE FOR PATIENTS DURING COVID. THE VIDEOS ARE AVAILABLE ON AIM AT MELANOMA SITE'S YOUTUBE CHANNEL.
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt02552720
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0175000
IRS990/PYInvestmentIncomeAmt018928
IRS990/PYOtherExpensesAmt01006121
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0533886
IRS990/PYSalariesCompEmpBnftPaidAmt0856641
IRS990/PYTotalExpensesAmt02037762
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt02571648
IRS990/QuidProQuoContributionsInd00
IRS990/ReconcilationRevenueExpnssAmt0516171
IRS990/RegularMonitoringEnfrcInd00
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RtnEarnEndowmentIncmOthFndsGrp/BOYAmt03106584
IRS990/RtnEarnEndowmentIncmOthFndsGrp/EOYAmt03622755
IRS990/SavingsAndTempCashInvstGrp/BOYAmt02470124
IRS990/SavingsAndTempCashInvstGrp/EOYAmt02503267
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt02133571
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt02552720
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt02540964
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt02411205
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt01781386
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt011419846
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt033124
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt018928
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt03344
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt01384
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt01495
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt058275
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt02681
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearAmt0168365
IRS990ScheduleA/OtherIncome170Grp/TotalAmt0168365
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.42710
IRS990ScheduleA/PublicSupportPY170Pct00.44110
IRS990ScheduleA/PublicSupportTotal170Amt04973695
IRS990ScheduleA/SubstantialContributorsTotAmt06446151
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt02133571
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt02552720
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt02540964
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt02411205
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt01781386
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt011419846
IRS990ScheduleA/TotalSupportAmt011646486
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/ExpensesNotReportedAmt00
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt00
IRS990ScheduleD/ExpensesSubtotalAmt01818889
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt024682
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt051319
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt076001
IRS990ScheduleD/OtherRevenuesNotIncludedAmt0201489
IRS990ScheduleD/RevenueNotReportedAmt00
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt0201489
IRS990ScheduleD/RevenueSubtotalAmt02133571
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0INVESTMENT INCOME 33,124. SBA PPP 164,745. MISC MISSION RELATED INCOME 3,620.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0PART XI, LINE 4B - OTHER ADJUSTMENTS:
IRS990ScheduleD/TotalBookValueLandBuildingsAmt024682
IRS990ScheduleD/TotalExpensesPerForm990Amt01818889
IRS990ScheduleD/TotalRevenuePerForm990Amt02335060
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt02133571
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt01818889
IRS990ScheduleG/FundraisingEventInformationGrp/Event1Nm0AIM FOR THE "CURE MELANOMA WALKS"
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/RecipientTable/CashGrantAmt08300
IRS990ScheduleI/RecipientTable/CashGrantAmt115000
IRS990ScheduleI/RecipientTable/CashGrantAmt250000
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0CANCER AND MELANOMA RESEARCH
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt1CANCER AND MELANOMA RESEARCH
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt2TISSUE BANK
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0OHSU KNIGHT CANCER INSTITUTE
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt1UPMC UNIV OF PITTSBURGH CANCER INSTITUTE
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt2MTBC MELANOMA TISSUE BANK CONSORTIUM
IRS990ScheduleI/RecipientTable/RecipientEIN0237083114
IRS990ScheduleI/RecipientTable/RecipientEIN1250965591
IRS990ScheduleI/RecipientTable/RecipientEIN2462454076
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt01121 SW SALMON STREET
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt15150 CENTRE AVENUE
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt2139 WATERSIDE CIRCLE
IRS990ScheduleI/RecipientTable/USAddress/CityNm0PORTLAND
IRS990ScheduleI/RecipientTable/USAddress/CityNm1PITTSBURGH
IRS990ScheduleI/RecipientTable/USAddress/CityNm2SAN RAFAEL
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0OR
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd1PA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd2CA
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd097205
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd115232
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd294903
IRS990ScheduleJ/AnyNonFixedPaymentsInd00
IRS990ScheduleJ/BoardOrCommitteeApprovalInd0X
IRS990ScheduleJ/CompBasedOnRevenueOfFlngOrgInd00
IRS990ScheduleJ/CompBsdNetEarnsFlngOrgInd00
IRS990ScheduleJ/CompBsdNetEarnsRltdOrgsInd00
IRS990ScheduleJ/CompBsdOnRevRelatedOrgsInd00
IRS990ScheduleJ/EquityBasedCompArrngmInd00
IRS990ScheduleJ/Form990OfOtherOrganizationsInd0X
IRS990ScheduleJ/InitialContractExceptionInd00
IRS990/ScheduleJRequiredInd01
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BaseCompensationFilingOrgAmt0160080
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BaseCompensationFilingOrgAmt1160508
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusFilingOrganizationAmount00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusFilingOrganizationAmount10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusRelatedOrganizationsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusRelatedOrganizationsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompensationBasedOnRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompensationBasedOnRltdOrgsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompReportPrior990FilingOrgAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompReportPrior990FilingOrgAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompReportPrior990RltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompReportPrior990RltdOrgsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/DeferredCompensationFlngOrgAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/DeferredCompensationFlngOrgAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/DeferredCompRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/DeferredCompRltdOrgsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/NontaxableBenefitsFilingOrgAmt021698
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/NontaxableBenefitsFilingOrgAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/NontaxableBenefitsRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/NontaxableBenefitsRltdOrgsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/OtherCompensationFilingOrgAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/OtherCompensationFilingOrgAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/OtherCompensationRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/OtherCompensationRltdOrgsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/PersonNm0SAMANTHA GUILD
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/PersonNm1ALICIA ROWELL
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TitleTxt0PRESIDENT AND DIRECTOR
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TitleTxt1EXECUTIVE ADMINISTRATOR
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TotalCompensationFilingOrgAmt0181778
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TotalCompensationFilingOrgAmt1160508
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TotalCompensationRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TotalCompensationRltdOrgsAmt10
IRS990ScheduleJ/SeverancePaymentInd00
IRS990ScheduleJ/SupplementalNonqualRtrPlanInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0FORM 990 IS SUBMITTED BY THE ACCOUNTANT TO THE GOVERNING BODY FOR REVIEW AND DISCUSSION. THE PRESIDENT APPROVES THE FILING OF FORM 990 BASED ON COMPLIANCE AND ACCURACY. THE ACCOUNTANT IS THEN GIVEN AUTHORIZATION TO FILE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1ALL GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND APPLICABLE FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2A COMMITTEE ASSUMES RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT, REVIEW OR COMPILATION OF ITS FINANCIAL STATEMENTS AND SELECTION OF ITS INDEPENDENT AUDITORS. THE ORGANIZATION DID NOT CHANGE ITS OVERSIGHT OR SELECTION PROCESS DURING THE TAX YEAR.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PART VI, SECTION B, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PART VI, SECTION C, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990 PART XII LINE 2C
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToExcsTaxNetInvstIncInd00
IRS990/SubjectToProxyTaxInd00
IRS990/SubjToTaxRmnrtnExPrchtPymtInd00

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2020 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$3,672,755
Liabilities
$50,000
Net assets
$3,622,755
Revenue
$2,335,060
Expenses
$1,818,889
Net income
$516,171
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$6.67$0.02$6.65$2.97$2.33$0.64
2023Detailed filing. Detailed filing data is available for this year.$6.02$0.02$6.01$3.25$2.31$0.93
2022Detailed filing. Detailed filing data is available for this year.$5.08$0.01$5.07$2.59$2.19$0.39
2021Detailed filing. Detailed filing data is available for this year.$4.69$0.01$4.68$2.90$1.84$1.06
2020Detailed filing. Detailed filing data is available for this year.$3.67$0.05$3.62$2.34$1.82$0.52
2019Detailed filing. Detailed filing data is available for this year.$3.23$0.12$3.11$2.57$2.04$0.53
2018Detailed filing. Detailed filing data is available for this year.$2.57$0.00$2.57$2.54$2.37$0.17
2017Detailed filing. Detailed filing data is available for this year.$2.40$0.00$2.40$2.42$2.07$0.34
2016Detailed filing. Detailed filing data is available for this year.$2.05$0.00$2.05$1.78$1.41$0.37
2015Detailed filing. Detailed filing data is available for this year.$1.68$0.00$1.68$1.65$1.27$0.38
2014Detailed filing. Detailed filing data is available for this year.$1.30$0.00$1.30$1.32$1.20$0.12
2013Detailed filing. Detailed filing data is available for this year.$1.18$0.00$1.18$1.24$1.18$0.06
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.12$0.00$1.12$0.87
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.84$0.00$0.83$0.87
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.46$0.00$0.46$0.75